Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tabalumab in rheumatoid arthritis patients on methotrexate
NCT00308282Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2006
- Primary completion
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tabalumab in rheumatoid arthritis (RA), sponsored by Eli Lilly and Company. Started Mar 2006; status: completed.
02
Drugs
tabalumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00308282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308282.